ADAR1 Capital Management »

Personalis Ord shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Personalis Ord (PSNL) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Personalis Ord

Tip: Access up to 7 years of quarterly data

All positions including Personalis Ord held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Personalis Ord by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $159k 25k 6.37

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Terns Pharmaceuticals Call Option (TERN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Crinetics Pharmaceuticals In (CRNX)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Denali Therapeutics (DNLI)
Beam Therapeutics (BEAM)
Zai Lab Adr (ZLAB)
Septerna (SEPN)
Vir Biotechnology (VIR)
Dbv Technologies S A Sponsored Ads (DBVT)

View all positions for ADAR1 Capital Management

Top funds holding Personalis Ord

Merck & Co
T. Rowe Price Investment Management
Lightspeed Management Company
ARK Investment Management
Ameriprise Financial
BlackRock
Standard Life Aberdeen
Vanguard Group
Deep Track Capital
AIGH Capital Management
Vanguard Capital Management
Kennedy Capital Management
Blue Water Life Science Advisors
Casdin Capital
Geode Capital Management

View all funds holding Personalis Ord